We are live on ! Find out more

18 hedge funds and large institutions have $2.15M invested in Imunon in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

21% more call options, than puts

Call options by funds: $64K | Put options by funds: $53K

13% more capital invested

Capital invested by funds: $1.91M → $2.15M (+$245K)

6% more funds holding

Funds holding: 1718 (+1)

0% more ownership

Funds ownership: 0.03%0.03% (+0%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
4
Closed
2
Calls
$64K
Puts
$53K
Net Calls
+$11K
Net Calls Change
+$187K

IMNN Hedge Fund Activity: Q2 2019 in Review

18 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2019, worth a combined $2.15M — up 13% from $1.91M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IMNN positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $441K. The largest seller was Group One Trading, cutting an estimated $85.2K.

  • 18 institutional investors held Imunon (IMNN) as of Q2 2019, up from 17 in Q1 2019.
  • Funds reported $2.15M of Imunon stock for Q2 2019, up 13% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q2 2019 and 2 closed out, a net change of +1 holder.
  • The largest Imunon buyer in Q2 2019 was Vanguard Group, an estimated $441K added.
  • The largest Imunon seller in Q2 2019 was Group One Trading, an estimated $85.2K sold.

Based on aggregated 13F filings for Q2 2019.